Top Industry Leaders in the Primary Aldosteronism Market
Latest Primary Aldosteronism Companies Updates:
Novartis expands access to Mineralo (spironolactone) Offering the medication in more dosage forms and launching patient support programs improves medication adherence and treatment outcomes.
Abbott receives FDA approval for AlinIQ Analyzer for rapid aldosterone testing This point-of-care technology allows for fast and accurate aldosterone level measurement, facilitating quicker diagnosis and treatment decisions.
Research on next-generation mineralocorticoid receptor antagonists Companies like Boehringer Ingelheim are developing new medications with improved side effect profiles and potentially longer-lasting effects for better PA management.
List of Primary Aldosteronism Key companies in the market:
- Canon Inc
- Pfizer Inc.
- Shimadzu Corporation
- Sun Pharmaceutical Industries Ltd.
- Shimadzu Corporation
- Bristol Laboratories Ltd
- Siemens AG
- Bristol Laboratories Ltd